Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Omega Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 63 | 1 | 70 | +8 |
| Shares | 50.2M | 10.0K | 51.1M | +913.2K (+1.8%) |
| Value | $151.2M | $30.0K | $186.6M | +$35.4M (+23.4%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Omega Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 144,000 | $525.6K | 0.01% |
| Marshall Wace, LLP | 59,547 | $217.3K | 0.00% |
| Gsa Capital Partners LLP | 23,649 | $86.0K | 0.01% |
| Citadel Advisors LLC | 23,500 | $85.8K | 0.00% |
| Cubist Systematic Strategies, LLC | 17,744 | $64.8K | 0.00% |
| Harbor Capital Advisors, Inc. | 16,775 | $61.0K | 0.01% |
| SEI Investments Co | 15,215 | $55.5K | 0.00% |
| Dimensional Fund Advisors LP | 12,210 | $44.6K | 0.00% |
| Ameriprise Financial Inc | 10,750 | $39.2K | 0.00% |
| Manufacturers Life Insurance Company, The | 10,530 | $38.4K | 0.00% |
| Colony Group, LLC | 10,000 | $25.0K | 0.00% |
| AllSquare Wealth Management LLC | 1,000 | $3.65K | 0.00% |
| Point72 (DIFC) Ltd | 549 | $2.00K | 0.00% |
| Harbour Investments, Inc. | 275 | $1.00K | 0.00% |
| Russell Investments Group, Ltd. | 116 | $423 | 0.00% |
| The PNC Financial Services Group, Inc. | 49 | $179 | 0.00% |
| Farther Finance Advisors, LLC | 38 | $122 | 0.00% |
| Nisa Investment Advisors, LLC | 17 | $62 | 0.00% |
| CWM, LLC | 2 | $0 | 0.00% |
Sold out (11)
Institutions that held Omega Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Zacks Investment Management | 306,426 | $922.3K |
| Squarepoint Ops LLC | 138,645 | $417.3K |
| Amundi | 26,347 | $110.9K |
| Jane Street Group, LLC | 31,261 | $94.1K |
| Two Sigma Investments, LP | 30,133 | $90.7K |
| Renaissance Technologies LLC | 20,400 | $61.0K |
| Etfidea, LLC | 13,050 | $39.3K |
| McGlone Suttner Wealth Management, Inc. | 6,591 | $19.8K |
| Raleigh Capital Management Inc. | 2,096 | $6.31K |
| Advisory Services Network, LLC | 638 | $1.92K |
| Allworth Financial LP | 268 | $807 |
Not filed for Q1 2024 yet (1)
Institutions that held Omega Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Wade G W & Inc | 10,000 | $30.0K |